Home Biosimilar Antibodies GPCR & G Protein Cannabinoid Receptor antibody Nimacimab (Anti-CB1 / CNR1) For research use only.
Not for use in humans.

Nimacimab (Anti-CB1 / CNR1)

Synonyms: RYI-018

Nimacimab (Anti-CB1/CNR1) is a negative-allosteric modulating monoclonal antibody targeting CB1 receptor. Nimacimab can be used for research of metabolic diseases. MW:145.5 KD.

Nimacimab (Anti-CB1 / CNR1)

Purity & Quality Control

Batch: A257401 Purity: 99% Protein concentration: 4.19mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Cannabinoid Receptor Inhibitors

Biological Activity

Description Nimacimab (Anti-CB1/CNR1) is a negative-allosteric modulating monoclonal antibody targeting CB1 receptor. Nimacimab can be used for research of metabolic diseases. MW:145.5 KD.

Product Details

CAS No. 2098636-09-8
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Nimacimab (Anti-CB1 / CNR1) | Nimacimab (Anti-CB1 / CNR1) supplier | purchase Nimacimab (Anti-CB1 / CNR1) | Nimacimab (Anti-CB1 / CNR1) cost | Nimacimab (Anti-CB1 / CNR1) manufacturer | order Nimacimab (Anti-CB1 / CNR1) | Nimacimab (Anti-CB1 / CNR1) distributor